Search the webpage

About the Company

The concept of Experimentica Ltd. is to bridge a gap between the development of novel in vitro, ex vivo and in vivo ocular models and their use in developing clinical applications as well as to draw upon academic knowledge in a contract based organization.

Management team

Giedrius Kalesnykas, PhD
Founder and Chief Executive Officer
.

ABOUT
Dr. Kalesnykas has extensive research experience in eye research and neuroscience developing neuronal based projects at the University of Eastern Finland and The Wilmer Eye Institute, The Johns Hopkins University, MD, USA. He brings his experience to the team as a consultant and contract researcher to several international companies in the area of histology, immunohistochemistry, stereology and ocular models.

Follow

Jenni J. Hakkarainen, PhD
Acting Chief Operating Officer
Director R&D Operations

ABOUT
Dr. Hakkarainen has a strong research background in ex vivo and in vitro drug permeability testing and prediction of drug transport across biological barriers, such as cornea, blood-brain barrier, intestine, and skin. She contributes many years’ experience working with in vitro cell culture, using primary endothelial and secondary epithelial cells and glioma cell lines. Dr. Hakkarainen received her Ph.D. in biopharmacy from the University of Eastern Finland.

Follow

Simon Kaja, PhD
Chief Scientific Officer
Director North American Operations

ABOUT
Dr. Kaja is an internationally recognized expert in experimental ophthalmology and neuroscience and regular consultant to both pharma and biotech companies. He has published over 50 peer-reviewed articles and book chapters. Dr. Kaja still maintains an active academic research program at the Loyola University Chicago, Stritch School of Medicine, Department of Ophthalmology, where he serves as Assistant Professor; Dr John P & Therese E Mulcahy Endowed Professor in Ophthalmology.

Follow

Satu Mering, PhD, Docent
Director Laboratory
Animal Research

ABOUT
Dr. Mering has over 20 years’ experience in the area of laboratory animal science, especially animal welfare. She received her Ph.D. in Applied Zoology from the University of Eastern Finland. Dr. Mering has broad regulatory expertise and serves as member on both the National Experimental Animal Board and the National Committee of the Council on the Protection of Animals Used for Scientific or Educational purposes. She has an excellent track-record in educating and training scientists at all levels in the use and care of laboratory animals. Dr. Mering will continue to serve as Chairperson of the Finnish Laboratory Animal Science Association (FinLAS).

Follow

Marc Cerrada-Gimenez, PhD
Director In Vivo Pharmacology
.

ABOUT
Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications. In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.

Follow